A structured search reveals that online marketing of stem-cell-based interventions is skewed toward developed economies including the United States, Ireland, Australia, and Germany. Websites made broad, imprecise therapeutic claims and frequently failed to detail procedures. Widespread marketing poses challenges to regulators, bioethicists, and those seeking realistic hope from therapies.
Berger, I., Ahmad, A., Bansal, A., Kapoor, T., Sipp, D., & Rasko, J. E. J. (2016, August 4). Global Distribution of Businesses Marketing Stem Cell-Based Interventions. Cell Stem Cell. Cell Press. https://doi.org/10.1016/j.stem.2016.07.015